| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2025 | AXGN Axogen, Inc. | Began Marc A | EVP &General Counsel | Sell | 9,278 | $31.21 | $289,547.82 | -22.7% | -4.3% | - | |
| Dec 9, 2025 | BLFS Biolife Solutions Inc | Foster Karen A.67 | Chief Quality And Operations | Sell | 519 | $25.13 | $13,042.47 | -0.3% | -19.6% | - | |
| Dec 9, 2025 | NSPR Inspiremd, Inc. | Stuka Paul | Director | Buy | 5,073 | $1.81 | $9,182.13 | +1.3% | -8.8% | - | |
| Dec 9, 2025 | ENOV Enovis Corp | Pryor Daniel A74 | Former EVP, Strategy &Bus Dev | Sell | 1,665 | $27.21 | $45,297.99 | -1.0% | -8.8% | - | |
| Dec 9, 2025 | AXGN Axogen, Inc. | Devinney Erick Wayne | Chief Innovation Officer | Sell | 19,517 | $31.21 | $609,086.54 | -7.5% | -4.3% | - | |
| Dec 9, 2025 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 631 | $25.13 | $15,857.03 | -0.2% | -19.6% | - | |
| Dec 9, 2025 | AXGN Axogen, Inc. | Tyndall Joseph A. | Director | Sell | 25,108 | $30.98 | $777,770.52 | -69.8% | -4.3% | - | |
| Dec 9, 2025 | AXGN Axogen, Inc. | Kemp Jens | Chief Marketing Officer | Sell | 8,156 | $31.21 | $254,532.45 | -15.1% | -4.3% | - | |
| Dec 9, 2025 | DXR Daxor Corp | Michel Robert J62 | Chief Financial Officer | Buy | 3,000 | $0.00 | - | +17.6% | -9.6% | - | |
| Dec 9, 2025 | SERA Sera Prognostics, Inc. | Aerts Austin77 | Chief Financial Officer | Sell | 5,232 | $3.04 | $15,905.28 | -1.9% | -37.1% | - | |
| Dec 9, 2025 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 358 | $25.13 | $8,996.54 | -0.3% | -19.6% | - | |
| Dec 9, 2025 | AXGN Axogen, Inc. | Dale Michael D64 | Chief Executive Officer | Sell | 61,463 | $31.21 | $1,918,137.30 | -41.0% | -4.3% | - | |
| Dec 9, 2025 | EW Edwards Lifesciences Corp | Ullem Scott B.65 | Cvp, Chief Financial Officer | Sell | 7,700 | $84.47 | $650,412.07 | -16.2% | +1.2% | - | |
| Dec 9, 2025 | SERA Sera Prognostics, Inc. | Lindgardt Zhenya75 | Chief Executive Officer | Sell | 28,215 | $3.04 | $85,773.60 | -3.5% | -37.1% | - | |
| Dec 9, 2025 | GKOS Glaukos Corp | Kliman Gilbert H64 | Director | Sell | 5,000 | $107.27 | $536,350.00 | -12.5% | -1.0% | - | |
| Dec 9, 2025 | EKSO Ekso Bionics Holdings, Inc. | Jones Jason C64 | Chief Operating Officer | Sell | 270 | $4.70 | $1,269.00 | -1.0% | +149.0% | - | |
| Dec 9, 2025 | DXR Daxor Corp | Feldschuh Jonathan Adam | Chief Scientific Officer | Buy | 18,000 | $0.00 | - | +50.1% | -9.6% | - | |
| Dec 9, 2025 | CBLL Ceribell, Inc. | Burke William W75 | Director | Sell | 32,728 | $22.02 | $720,670.56 | -48.5% | -13.9% | - | |
| Dec 9, 2025 | IRMD Iradimed Corp | Hawkins James B60 | - | Sell | 3,000 | $96.61 | $289,837.50 | -9.5% | +3.6% | - | |
| Dec 9, 2025 | ATEC Alphatec Holdings, Inc. | Squadron Capital Holdings LLC63 | 10% Owner | Sell | 250,000 | $21.18 | $5,295,098.22 | -1.2% | -37.7% | - | |
| Dec 9, 2025 | ATEC Alphatec Holdings, Inc. | Squadron Capital LLC63 | 10% Owner | Sell | 250,000 | $21.18 | $5,295,098.22 | -1.2% | -37.7% | - | |
| Dec 9, 2025 | AXGN Axogen, Inc. | Johnson John | Director | Sell | 45,379 | $30.64 | $1,390,392.87 | -53.5% | -4.3% | - | |
| Dec 9, 2025 | ATEC Alphatec Holdings, Inc. | Pritzker Jennifer N.49 | 10% Owner | Sell | 250,000 | $21.18 | $5,295,098.22 | -1.2% | -37.7% | - | |
| Dec 9, 2025 | ATEC Alphatec Holdings, Inc. | Pelizzon David R56 | Director, 10% Owner | Sell | 250,000 | $21.18 | $5,295,098.22 | -1.2% | -37.7% | - | |
| Dec 9, 2025 | BFLY Butterfly Network, Inc. | Rothberg Jonathan M71 | Director, 10% Owner | Sell | 945,397 | $3.24 | $3,064,544.25 | -70.4% | +21.3% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.